Page 47 - GTM-2-4

Global Translational Medicine The research advances in HPV integration

https://doi.org/10.1007/s00404-022-06748-1 J Med Virol, 95: e28761.
95. Tian R, Wang Y, Li W, et al., 2022, Genome-wide virus- https://doi.org/10.1002/jmv.28761
integration analysis reveals a common insertional mechanism 106. Akagi K, Symer DE, Mahmoud M, et al., 2023, Intratumoral
of HPV, HBV and EBV. Clin Transl Med, 12: e971.
heterogeneity and clonal evolution induced by HPV
https://doi.org/10.1002/ctm2.971 integration. Cancer Discov, 13: 910–927.
96. Hesselberg Lovestad A, Stosic MS, Costanzi JM, et al., https://doi.org/10.1158/2159-8290.Cd-22-0900
2023, TaME-seq2: Tagmentation-assisted multiplex PCR
enrichment sequencing for viral genomic profiling. Virol J, 107. Huang KB, Guo SJ, Li YH, et al., 2021, Genome-wide
20: 44. profiling reveals HPV integration pattern and activated
carcinogenic pathways in penile squamous cell carcinoma.
https://doi.org/10.1186/s12985-023-02002-5 Cancers (Basel), 13: 6104.
97. Van Arsdale A, Patterson NE, Maggi EC, et al., 2020, https://doi.org/10.3390/cancers13236104
Insertional oncogenesis by HPV70 revealed by multiple
genomic analyses in a clinically HPV-negative cervical 108. Aldersley J, Lorenz DR, Mouw KW, et al., 2021, Genomic
cancer. Genes Chromosomes Cancer, 59: 84–95. landscape of primary and recurrent anal squamous cell
carcinomas in relation to HPV integration, copy-number
https://doi.org/10.1002/gcc.22799 variation, and DNA damage response genes. Mol Cancer
98. Yang S, Zhao Q, Tang L, et al., 2021, Whole genome Res, 19: 1308–1321.
assembly of human papillomavirus by nanopore long-read https://doi.org/10.1158/1541-7786.MCR-20-0884
sequencing. Front Genet, 12: 798608.
109. Nagarsheth NB, Norberg SM, Sinkoe AL, et al., 2021, TCR-
https://doi.org/10.3389/fgene.2021.798608 engineered T cells targeting E7 for patients with metastatic
99. Zeng X, Wang Y, Liu B, et al., 2023, Multi-omics data reveals HPV-associated epithelial cancers. Nat Med, 27: 419–425.
novel impacts of human papillomavirus integration on https://doi.org/10.1038/s41591-020-01225-1
the epigenomic and transcriptomic signatures of cervical
tumorigenesis. J Med Virol, 95: e28789. 110. Doran SL, Stevanovic S, Adhikary S, et al., 2019, T-cell
receptor gene therapy for human papillomavirus-associated
https://doi.org/10.1002/jmv.28789 epithelial cancers: A first-in-human, phase I/II study. J Clin
100. Fan J, Fu Y, Peng W, et al., 2023, Multi-omics characterization Oncol, 37: 2759–2768.
of silent and productive HPV integration in cervical cancer. https://doi.org/10.1200/JCO.18.02424
Cell Genom, 3: 100211.
111. Ramos CA, Narala N, Vyas GM, et al., Human papillomavirus
https://doi.org/10.1016/j.xgen.2022.100211 type 16 E6/E7-specific cytotoxic T lymphocytes for
101. Tian R, Huang ZY, Li LF, et al., 2023, HPV integration adoptive immunotherapy of HPV-associated malignancies.
generates a cellular super-enhancer which functions as J Immunother, 36: 66–76.
ecDNA to regulate genome-wide transcription. Nucleic https://doi.org/10.1097/CJI.0b013e318279652e
Acids Res, 51: 4237–4251.
112. Zhang XQ, Luo MY, Dastagir SR, et al., 2021, Engineered
https://doi.org/10.1093/nar/gkad105 red blood cells as an off-the-shelf allogeneic anti-tumor
102. Wang X, Jia W, Wang M, et al., 2022, Human papillomavirus therapeutic. Nat Commun, 12: 2637.
integration perspective in small cell cervical carcinoma. Nat https://doi.org/10.1038/s41467-021-22898-3
Commun, 13: 5968.
113. Basu P, Mehta A, Jain M, et al., 2018, A randomized phase
https://doi.org/10.1038/s41467-022-33359-w 2 study of ADXS11-001 listeria monocytogenes-listeriolysin
103. Li W, Lei W, Chao X, et al., 2021, Genomic alterations caused O immunotherapy with or without cisplatin in treatment of
by HPV integration in a cohort of Chinese endocervical advanced cervical cancer. Int J Gynecol Cancer, 28: 764–772.
adenocarcinomas. Cancer Gene Ther, 28: 1353–1364. https://doi.org/10.1097/Igc.0000000000001235
https://doi.org/10.1038/s41417-020-00283-4 114. Rebucci-Peixoto M, Vienot A, Adotevi O, et al., 2022, A
104. Gu W, Bhangale A, Heft Neal ME, et al., 2022, Analysis phase II study evaluating the interest to combine UCPVax,
of human papilloma virus content and integration in a telomerase CD4 T(H)1-inducer cancer vaccine, and
mucoepidermoid carcinoma. Viruses, 14: 2353. atezolizumab for the treatment of HPV positive cancers:
VolATIL study. Front Oncol, 12: 957580.
https://doi.org/10.3390/v14112353
https://doi.org/10.3389/fonc.2022.957580
105. Xu Q, Dong H, Wang Z, et al., 2023, Integration and viral
oncogene expression of human papillomavirus type 16 in 115. Adotevi O, Vernerey D, Jacoulet P, et al., 2023, Safety,
oropharyngeal squamous cell carcinoma and gastric cancer. immunogenicity, and 1-year efficacy of universal cancer

Volume 2 Issue 4 (2023) 21 https://doi.org/10.36922/gtm.2034